Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs - CNBC
- Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs CNBC
- Pfizer, Already In Buy Zone, Rises On Strong Earnings, Guidance Investor's Business Daily
- Pfizer raises annual profit forecast after better-than-expected COVID sales Yahoo Finance
- Pfizer stock gains after raising annual earnings outlook (NYSE:PFE) Seeking Alpha
- Pfizer Lifts Outlook as Company Seeks to Rebuild Post-Covid Bloomberg